TheraCell was founded in 2008 to exploit technology developed at the Hebrew University by leading researcher Dan Gazit PhD and his team. The technology included a stem cell sorting device to concentrate MSC’s from adipose tissue and Oxygenation technology to improve survival of stem cell solutions.

Guided by a team of influential spine surgeons, and led by experienced Medical Device executives, TheraCell has further developed methodologies and gained patent protection for applying the oxygenation technology to demineralized bone matrix products. We have also developed a proprietary, patent pending process for the production of demineralized bone fibers. Our DBF™ technology has allowed the development of a number of Fiber Matrix™ products. We also have a proprietary, patent pending process to enhance the osteoinductivity of demineralized cancellous bone.

TheraCell established an R&D laboratory in Massachusetts in November 2013.